FDA Warning Letter — Cholrem USA

Case 684036 — FEI 3030694317

The FDA took a Warning Letter action against Cholrem USA on Jul 9, 2024 (Salt Lake City, UT). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Cholrem USA
Date
Jul 9, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Salt Lake City, UT (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.